Defendant

Par Pharmaceuticals, Inc.

1 case as defendant.

Cases
1
Active
0
1 closed
Filed
2013
Top venue
D N J
1 case

Jazz Pharmaceuticals, Inc. v. Par Pharmaceuticals, Inc.

settled
Docket:
2:13-cv-07884
Court:
D.N.J.
Filed:
2013-12-27
Terminated:
2018-01-09
Patents:7765107
π Jazz Pharmaceuticals, Inc.Δ Par Pharmaceuticals, Inc.

ANDA Hatch-Waxman action by Jazz Pharmaceuticals against Par Pharmaceuticals involving Xyrem and US 7,765,107. Par's Paragraph IV notice was dated November 20, 2013; the case later settled on January 9, 2018 with an authorized-generic license.